Christian Klein
Researcher Next ID · RN-034056
Researcher · Immunology and Microbiology
Basel, Switzerland
- Works count
- 1,069
- Citation count
- 28,957
- H-index
- 78
- i10-index
- 274
Research interests
Publications
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
Annals of Surgery · 2020 · https://doi.org/10.1097/sla.0000000000004280
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial
Blood · 2019 · https://doi.org/10.1182/blood-2018-11-880526
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0057-z
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment
Cancer Cell · 2017 · https://doi.org/10.1016/j.ccell.2017.02.002
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
Transplantation · 2015 · https://doi.org/10.1097/tp.0000000000000965
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Journal of Clinical Investigation · 2012 · https://doi.org/10.1172/jci58832
Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation
Transplant International · 2011 · https://doi.org/10.1111/j.1432-2277.2011.01254.x
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Proceedings of the National Academy of Sciences · 2011 · https://doi.org/10.1073/pnas.1019002108
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity
Blood · 2010 · https://doi.org/10.1182/blood-2009-06-225979
STAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo
Gastroenterology · 2006 · https://doi.org/10.1053/j.gastro.2006.10.018
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Science · 2004 · https://doi.org/10.1126/science.1092472
Current projects
No projects listed.